NDC 42023-173-01 - Ganciclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42023-173
- Requested NDC
- 42023-173-01
- Package NDCs from labels
- 42023-173-01, 42023-173-25
- Manufacturer
- Par Health USA, LLC
- Effective date
- 2026-09-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ganciclovir - Par Health USA, LLC | Par Health USA, LLC | 2026-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42023-173-01 | Ganciclovir | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 10 | 7 | |
| 42023-173-25 | Ganciclovir | 25 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 25 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42023-173-01 | EA - Each | 42023-173 | 8ed1ce31-c975-4e0d-ac0b-03e3fd359d8c | 1 | 2017-05-03 |
| 42023-173-25 | EA - Each | 42023-173 | 958a7e80-41eb-4b06-b208-7de784dfa193 | 1 | 2017-05-03 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ganciclovir | GANCICLOVIR SODIUM | Fresenius Kabi USA, LLC | b47f5d1c-36b8-49b6-a410-3b3f4661dde7 | 2026-01-09 | Boxed warning, Warnings, Adverse reactions | 310442 02L083W284 |
| Ganciclovir | GANCICLOVIR SODIUM | Fresenius Kabi USA, LLC | 35addab5-09db-4f8a-9c69-6fbce33ecc37 | 2026-01-09 | Boxed warning, Warnings, Adverse reactions | 310442 02L083W284 |
| Ganciclovir | GANCICLOVIR SODIUM | Hikma Pharmaceuticals USA Inc. | 4f8219ca-6780-4131-8962-9c3fdd0a84dd | 2025-02-07 | Boxed warning, Warnings, Adverse reactions | 310442 02L083W284 |
| ganciclovir | GANCICLOVIR SODIUM | Slate Run Pharmaceuticals, LLC | eb100366-2a64-4742-af11-6177a8a494c8 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 310442 02L083W284 |
| ganciclovir sodium | GANCICLOVIR SODIUM | Slate Run Pharmaceuticals, LLC | cd293b9d-b573-4656-8574-19d7db870a9b | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 310442 02L083W284 |
| Ganciclovir | GANCICLOVIR SODIUM | Pharmascience Inc. | 3059c2da-d4a7-4aea-828c-20e671cb875c | 2022-12-21 | Boxed warning, Warnings, Adverse reactions | 02L083W284 |
| f04cdda8-4829-4fa1-8cf2-503479c89b1e | 87afd103-6e64-444f-971d-0e732e9ae995 | 2020-12-24 | Boxed warning, Warnings, Adverse reactions | f04cdda8-4829-4fa1-8cf2-503479c89b1e 87afd103-6e64-444f-971d-0e732e9ae995 | ||
| ganciclovir | GANCICLOVIR SODIUM | Sagent Pharmaceuticals | 993151ed-cea7-49a7-a967-fac3e9b3c85f | 2020-11-30 | Boxed warning, Warnings, Adverse reactions | 02L083W284 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.